Breaking News

Effort Launched to Create 340C—a Separate Drug Discount Program for Health Centers and Possibly Other Entities

Advocates for Community Health wordmark
The health center advocacy group behind a proposed 340B program alternative recently slammed the 340B ACCESS Act, saying the newly introduced drug discount program overhaul bill would make it harder for members to leverage the 340B program and care for patients.

A national community health center association founded last year is launching a campaign to urge Congress to create a separate drug discount program called 340C open to health centers and perhaps rural hospitals and federal grantees.

According to a description

Read More »

Congressman Who Represents Virginia 340B Hospital Profiled by New York Times Is Exploring Oversight and Legislation

Richmond Community Hospital signage and building
U.S. Rep. A. Donald McEachin (D-Va.) is exploring legislative responses to a controversy over a health system's alleged neglect of a profitable 340B hospital in a predominantly Black neighborhood.

The congressman who represents Richmond, Va., told a health system Wednesday he rejects its reasons for ceasing intensive care, maternity, and other vital services at a Richmond hospital in a mainly Black neighborhood despite the hospital allegedly earning millions of

Read More »

With Elections Nearing, Biden Is Ordering HHS to do More to Drive Drug Costs Down

Joe Biden holding microphone
President Biden will sign an executive order today directing HHS to submit a plan in 90 days "to lower drug costs and promote access to innovative drug therapies for Medicare beneficiaries."

President Biden will sign an executive order today directing the U.S. Health and Human Services Department (HHS) “to consider additional actions to further drive down prescription drug costs,” the White House said this morning.

“Under the Executive Order, HHS will

Read More »

PhRMA Makes its Case for Invalidating Arkansas’s First-of-its-Kind 340B Contract Pharmacy Law

PhRMA wordmark repeated on blue background
"There is no room for states, pharmacies, or other interests to step in and try to supplant” the federal government’s exclusive control over the 340B program, PhRMA told a federal district court in Arkansas late last week.

The 340B program “has always been uniquely federal in nature” and “there is no room for states, pharmacies, or other interests to step in and try to supplant” the federal government’s exclusive control over it, the brand drug industry said

Read More »

340B Pharmacy Services Company Avita Expands into Clinician and Support Staff Services

Michael Yount, Avita headshot
Maintaining regular access to providers is a challenge for many 340B grantee entities and can make it hard for them to leverage the 340B program, Avita CEO Michael Yount says.

Avita, a leading provider of 340B contract pharmacy and third-party administration services geared toward HIV and LGBTQ+ communities, is expanding into medical practice staffing and management.

Avita announced Oct. 5 that it has acquired HIV/AIDS, LGBTQ+, and primary care health

Read More »

340B Report Holding Oct. 28 Webinar on What the Midterm Elections Mean for 340B

Vote Here sign in English, Spanish and Chinese on Election Day
340B Report is holding a webinar Oct. 28 about 340B’s future after the November midterm elections.

Five Washington insiders steeped in knowledge about the 340B program will take part in a 340B Report webinar Oct. 28 about 340B’s future after the November midterm elections.

The event from 1:00 to 2:15 p.m. Eastern is an exclusive free

Read More »

CBO Raises Changing 340B Patient Definition to Ease Pressure on Commercial Insurers

Congressional Budget Office report title page
Changing the 340B patient definition “might reduce hospitals’ and physicians’ incentives to consolidate,” the CBO says in a new analysis.

Changing the 340B patient definition “might reduce hospitals’ and physicians’ incentives to consolidate,” but to what extent “remains highly uncertain,” the Congressional Budget Office says in a new policy analysis.

House Budget Committee Chair John Yarmuth (D-Ky.) asked CBO to

Read More »

UCB Files 340B Contract Pharmacy Suit Against HHS, the Ninth Company to Do So

UCB signage and building
UCB announced it will tighten its existing 340B contract restrictions on hospitals beginning Oct. 2.

Drug manufacturer UCB has sued in federal court to overturn federal health officials’ finding that the Belgian company’s restrictions on 340B pricing when covered entities use contract pharmacies are illegal and must stop or the company could face civil monetary

Read More »

U.S. Appeals Court Tentatively Set to Hear Three 340B Contract Pharmacy Cases on Nov. 15

U.S. Third Circuit Court of Appeals court house entrance
A federal appeals court in Philadelphia is currently set to hear arguments in a trio of key 340B contract pharmacy cases on Nov. 15.

As we first reported Friday in a news alert, a federal appeals court in Philadelphia has tentatively scheduled oral arguments in three key 340B contract pharmacy lawsuits for Nov. 15.

The clerk of the U.S. Third Circuit Court of Appeals

Read More »

PhRMA, BIO, and Others Unleash a Torrent of 340B Hospital Criticism

screenshot of PhRMA blog post September 15, 2022
Headline from recent blog post by PhRMA spokesperson Nicole Longo.

340B disproportionate share hospitals (DSH) in 2020 spent 2.2 times more on outpatient drugs per commercially insured patient than non-340B DSH hospitals and 2.6 times more than other types of 340B hospitals, a new drug industry-funded study shows.

The

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live